Fox & Science Limited 13409802 false 2022-06-01 2023-05-31 2023-05-31 The principal activity of the company is management consultancy. Digita Accounts Production Advanced 6.30.9574.0 true 13409802 2022-06-01 2023-05-31 13409802 2023-05-31 13409802 core:CurrentFinancialInstruments core:WithinOneYear 2023-05-31 13409802 bus:SmallEntities 2022-06-01 2023-05-31 13409802 bus:AuditExemptWithAccountantsReport 2022-06-01 2023-05-31 13409802 bus:FullAccounts 2022-06-01 2023-05-31 13409802 bus:SmallCompaniesRegimeForAccounts 2022-06-01 2023-05-31 13409802 bus:RegisteredOffice 2022-06-01 2023-05-31 13409802 bus:Director1 2022-06-01 2023-05-31 13409802 bus:PrivateLimitedCompanyLtd 2022-06-01 2023-05-31 13409802 countries:EnglandWales 2022-06-01 2023-05-31 13409802 2021-06-01 2022-05-31 13409802 2022-05-31 13409802 core:CurrentFinancialInstruments core:WithinOneYear 2022-05-31 iso4217:GBP xbrli:pure

Registration number: 13409802

Report of the Director and


Annual Report and Unaudited Financial Statements

for the Year Ended 31 May 2023

for
 

Fox & Science Limited

 

Fox & Science Limited

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3 to 4

 

Fox & Science Limited

Company Information

Director:

J Fuchs

Registered office:

Savoy House
Savoy Circus
London
W3 7DA

Registered number:

13409802

Accountants:

Wem & Co
Chartered Accountants
Savoy House
Savoy Circus
London
W3 7DA

 

Fox & Science Limited

(Registration number: 13409802)
Balance Sheet as at 31 May 2023

Note

31.05.23

31.05.22

   

£

£

£

£

CURRENT ASSETS

   

 

Cash at bank and in hand

   

74

 

2,074

CREDITORS

   

 

Creditors within 1yr

4

 

4,184

 

5,500

Net liabilities

   

(4,110)

 

(3,426)

CAPITAL AND RESERVES

   

 

Called up share capital

 

100

 

100

Profit and loss account

 

(4,210)

 

(3,526)

Shareholders' deficit

   

(4,110)

 

(3,426)

For the financial year ending 31 May 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 16 February 2024

.........................................
J Fuchs
Director

 

Fox & Science Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 May 2023

1.

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Savoy House
Savoy Circus
London
W3 7DA
England

These financial statements were authorised for issue by the director on 16 February 2024.

2.

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

The presentational currency is Pound Sterling (£).

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

 

Fox & Science Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 May 2023 (continued)

3.

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 0 (2022 - 0).

4.

Creditors

Creditors: amounts falling due within one year

31.05.23
£

31.05.22
£

Due within one year

Accruals and deferred income

1,284

600

Other creditors

2,900

4,900

4,184

5,500